32
total announcements
BAJAJHCARE.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹1,115 Cr
P/E (TTM)
47.8
EPS (TTM)
₹6.93
52W Low
₹272.35
52W High
₹490.00
Dividend Yield
0.46%
Beta
0.28
Price / Book
2.0
Debt / Equity
46.7
Revenue (TTM)
₹628 Cr
Gross Margin
48.73%
Operating Margin
13.12%
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange regarding the grant of 275 stock options to eligible employees under the Bajaj Healthcare Limited Employee Stock Option Plan 2024 at an exercise price of Rs. 5/- each.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue up 11.3% YoY, EBITDA up 16.4% YoY, and PAT up 15.8% YoY.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, confirming no deviation or variation in the utilisation of proceeds raised through the allotment of Equity Shares.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has received a Monitoring Agency Report from CARE Ratings Limited for the quarter ended June 30, 2026, regarding the utilization of proceeds raised through the preferential issue of equity shares and conversion of warrants into equity shares.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange about change in Management, continuation of directorship of Mr. Gopalakrishnan Kesavan as a Non-Executive Independent Director of the Company upon attaining the age of 75 years.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has submitted its unaudited standalone financial results for the quarter ended June 30, 2026, along with the Limited Review Report issued by Walker Chandiok & Co LLP, Chartered Accountants, Statutory Auditors of the Company.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has scheduled an earnings call to discuss its financial performance for Q1 FY27 on July 21, 2026, at 4:00 pm IST.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange about the schedule of its earnings call to discuss the financial performance for Q1 FY27.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities and listing on stock exchanges.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has received a recommendation from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) for the grant of permission to manufacture and market Cenobamate Tablets.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, due to the sale of its operational business unit and the declaration of un-audited financial results.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has approved the sale of an operational business unit located in Tarapur for up to ₹4.05 Crores, with completion expected by October 31, 2026. This unit contributed a minor 0.54% to the company's revenue and 0.74% to its net worth in the last financial year, indicating a negligible financial impact. The buyer, M/s Orchem Products, is an unrelated party, and the transaction is not considered a related party transaction.